Update: 25.06.2024
Last week: 24 week 2024 (10.06.2024 - 16.06.2024)
Last full month: May 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 6 844 | -4.0% | 12.0% | 1.2 | 14 175 467 | -5.7% | 9.4% | 0.9 | -13.7% |
| MoM | 30 129 | -17.3% | 11.2% | -0.3 | 65 855 813 | -18.2% | 9.3% | -0.4 | -15.3% |
| YTD | 172 767 | 20.1% | 11.1% | 2.4 | 382 638 862 | 46.1% | 9.4% | 2.1 | -5.8% |
| MAT | 369 799 | 29.5% | 10.2% | 1.9 | 777 536 419 | 49.1% | 8.6% | 1.5 | 5.6% |
| BRAINMAX | |||||||||
| WoW | 1 074 | -4.6% | 100.0% | 0 | 3 986 565 | -3.2% | 100.0% | 0 | -4.6% |
| MoM | 4 260 | -14.9% | 100.0% | 0 | 15 726 416 | -12.6% | 100.0% | 0 | -11.4% |
| YTD | 24 752 | 42.1% | 100.0% | 0 | 89 819 689 | 53.2% | 100.0% | 0 | 42.1% |
| MAT | 53 983 | 95.5% | 100.0% | 0 | 192 182 972 | 110.3% | 100.0% | 0 | 95.5% |
| GOLDLINE PLUS | |||||||||
| WoW | 18 436 | -1.4% | 45.9% | -0.2 | 57 066 839 | -1.2% | 37.9% | 0.3 | -1.0% |
| MoM | 77 761 | -2.4% | 44.6% | -1.1 | 241 414 256 | -3.8% | 36.0% | -1.3 | 0.1% |
| YTD | 415 087 | -2.2% | 44.6% | 1.2 | 1 311 930 733 | 1.7% | 36.4% | -2.8 | -4.9% |
| MAT | 859 800 | 10.2% | 45.5% | 1.3 | 2 713 056 964 | 17.6% | 38.2% | -1 | 7.0% |
| MIGRENIUM | |||||||||
| WoW | 10 812 | -13.0% | 0.5% | -0.1 | 3 593 308 | -10.9% | 0.7% | -0.1 | -2.1% |
| MoM | 47 431 | -22.4% | 0.5% | -0.1 | 15 520 654 | -19.7% | 0.7% | -0.1 | -5.4% |
| YTD | 290 484 | 0.0% | 0.6% | -0.1 | 87 713 171 | 67.3% | 0.7% | 0.2 | 13.9% |
| MAT | 641 708 | 4.0% | 0.5% | -0.1 | 157 953 060 | 41.0% | 0.6% | 0 | 17.1% |
| MODELAX-N | |||||||||
| WoW | 31 095 | 4.7% | 26.4% | 2.3 | 13 805 661 | 4.8% | 17.5% | 1.5 | -4.6% |
| MoM | 114 358 | -16.8% | 21.2% | -3.6 | 51 176 839 | -13.5% | 14.1% | -2.2 | -2.5% |
| YTD | 734 118 | 44.2% | 23.5% | 4.9 | 309 861 242 | 94.0% | 15.0% | 4.5 | 14.1% |
| MAT | 1 393 104 | 79.4% | 20.9% | 6.7 | 532 934 881 | 113.1% | 12.6% | 4.4 | 22.3% |
| REDUXIN | |||||||||
| WoW | 12 679 | -1.7% | 31.5% | -0.2 | 66 263 777 | -3.1% | 44.0% | -0.6 | -1.0% |
| MoM | 58 125 | 2.5% | 33.3% | 0.8 | 312 000 841 | 1.8% | 46.6% | 1 | 0.1% |
| YTD | 306 987 | -8.2% | 33.0% | -1.2 | 1 659 898 831 | 18.7% | 46.1% | 3.6 | -4.9% |
| MAT | 610 390 | 0.0% | 32.3% | -2.3 | 3 134 129 564 | 23.8% | 44.2% | 1.1 | 7.0% |
| REDUXIN FORTE | |||||||||
| WoW | 3 585 | 0.9% | 8.9% | 0.2 | 15 240 101 | -1.5% | 10.1% | 0 | -1.0% |
| MoM | 14 818 | -2.2% | 8.5% | -0.2 | 64 281 430 | -0.5% | 9.6% | 0 | 0.1% |
| YTD | 80 749 | 3.9% | 8.7% | 0.7 | 351 507 770 | 20.2% | 9.8% | 0.9 | -4.9% |
| MAT | 169 018 | 22.6% | 9.0% | 1.1 | 712 553 133 | 36.0% | 10.0% | 1.1 | 7.0% |
| SALVISAR | |||||||||
| WoW | 8 658 | -16.6% | 1.2% | -0.1 | 3 783 130 | -13.0% | 1.1% | -0.1 | -7.4% |
| MoM | 52 155 | -12.0% | 1.6% | -0.1 | 21 993 076 | -9.9% | 1.5% | -0.1 | -5.5% |
| YTD | 254 452 | 2.4% | 1.4% | 0 | 101 286 590 | 26.3% | 1.3% | 0.1 | 2.3% |
| MAT | 504 368 | -12.8% | 1.2% | -0.3 | 184 859 728 | -5.4% | 1.1% | -0.3 | 7.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 172 767 | 20.1% | 11.1% | 2.4 | 382 638 862 | 46.1% | 9.4% | 2.1 | -5.8% |
| BRAINMAX | 24 752 | 42.1% | 100.0% | 0 | 89 819 689 | 53.2% | 100.0% | 0 | 42.1% |
| GOLDLINE PLUS | 415 087 | -2.2% | 44.6% | 1.2 | 1 311 930 733 | 1.7% | 36.4% | -2.8 | -4.9% |
| MIGRENIUM | 290 484 | 0.0% | 0.6% | -0.1 | 87 713 171 | 67.3% | 0.7% | 0.2 | 13.9% |
| MODELAX-N | 734 118 | 44.2% | 23.5% | 4.9 | 309 861 242 | 94.0% | 15.0% | 4.5 | 14.1% |
| REDUXIN CAPS | 306 987 | -8.2% | 33.0% | -1.2 | 1 659 898 831 | 18.7% | 46.1% | 3.6 | -4.9% |
| REDUXIN FORTE | 80 749 | 3.9% | 8.7% | 0.7 | 351 507 770 | 20.2% | 9.8% | 0.9 | -4.9% |
| SALVISAR | 254 452 | 2.4% | 1.4% | 0 | 101 286 590 | 26.3% | 1.3% | 0.1 | 2.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 369 799 | 29.5% | 10.2% | 1.9 | 777 536 419 | 49.1% | 8.6% | 1.5 | 5.6% |
| BRAINMAX | 53 983 | 95.5% | 100.0% | 0 | 192 182 972 | 110.3% | 100.0% | 0 | 95.5% |
| GOLDLINE PLUS | 859 800 | 10.2% | 45.5% | 1.3 | 2 713 056 964 | 17.6% | 38.2% | -1 | 7.0% |
| MIGRENIUM | 641 708 | 4.0% | 0.5% | -0.1 | 157 953 060 | 41.0% | 0.6% | 0 | 17.1% |
| MODELAX-N | 1 393 104 | 79.4% | 20.9% | 6.7 | 532 934 881 | 113.1% | 12.6% | 4.4 | 22.3% |
| REDUXIN CAPS | 610 390 | 0.0% | 32.3% | -2.3 | 3 134 129 564 | 23.8% | 44.2% | 1.1 | 7.0% |
| REDUXIN FORTE | 169 018 | 22.6% | 9.0% | 1.1 | 712 553 133 | 36.0% | 10.0% | 1.1 | 7.0% |
| SALVISAR | 504 368 | -12.8% | 1.2% | -0.3 | 184 859 728 | -5.4% | 1.1% | -0.3 | 7.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 6 844 | -4.0% | 12.0% | 1.2 | 14 175 467 | -5.7% | 9.4% | 0.9 | -13.7% |
| BRAINMAX | 1 074 | -4.6% | 100.0% | 0 | 3 986 565 | -3.2% | 100.0% | 0 | -4.6% |
| GOLDLINE PLUS | 18 436 | -1.4% | 45.9% | -0.2 | 57 066 839 | -1.2% | 37.9% | 0.3 | -1.0% |
| MIGRENIUM | 10 812 | -13.0% | 0.5% | -0.1 | 3 593 308 | -10.9% | 0.7% | -0.1 | -2.1% |
| MODELAX-N | 31 095 | 4.7% | 26.4% | 2.3 | 13 805 661 | 4.8% | 17.5% | 1.5 | -4.6% |
| REDUXIN CAPS | 12 679 | -1.7% | 31.5% | -0.2 | 66 263 777 | -3.1% | 44.0% | -0.6 | -1.0% |
| REDUXIN FORTE | 3 585 | 0.9% | 8.9% | 0.2 | 15 240 101 | -1.5% | 10.1% | 0 | -1.0% |
| SALVISAR | 8 658 | -16.6% | 1.2% | -0.1 | 3 783 130 | -13.0% | 1.1% | -0.1 | -7.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 30 129 | -17.3% | 11.2% | -0.3 | 65 855 813 | -18.2% | 9.3% | -0.4 | -15.3% |
| BRAINMAX | 4 260 | -14.9% | 100.0% | 0 | 15 726 416 | -12.6% | 100.0% | 0 | -11.4% |
| GOLDLINE PLUS | 77 761 | -2.4% | 44.6% | -1.1 | 241 414 256 | -3.8% | 36.0% | -1.3 | 0.1% |
| MIGRENIUM | 47 431 | -22.4% | 0.5% | -0.1 | 15 520 654 | -19.7% | 0.7% | -0.1 | -5.4% |
| MODELAX-N | 114 358 | -16.8% | 21.2% | -3.6 | 51 176 839 | -13.5% | 14.1% | -2.2 | -2.5% |
| REDUXIN CAPS | 58 125 | 2.5% | 33.3% | 0.8 | 312 000 841 | 1.8% | 46.6% | 1 | 0.1% |
| REDUXIN FORTE | 14 818 | -2.2% | 8.5% | -0.2 | 64 281 430 | -0.5% | 9.6% | 0 | 0.1% |
| SALVISAR | 52 155 | -12.0% | 1.6% | -0.1 | 21 993 076 | -9.9% | 1.5% | -0.1 | -5.5% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"## [1] "MODELAX-N"## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"## [1] "AMBENE BIO"## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"## [1] "AMBENE BIO"## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"## [1] "MIGRENIUM"## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"## [1] "MIGRENIUM"## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"## [1] "SALVISAR"## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"## [1] "SALVISAR"## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"## [1] "REDUXIN CAPS"## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"## [1] "REDUXIN CAPS"## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"## [1] "REDUXIN FORTE"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"## [1] "REDUXIN FORTE"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"## [1] "GOLDLINE PLUS"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"## [1] "GOLDLINE PLUS"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX CAPS 250 MG+250 MG #40"## [1] "BRAINMAX CAPS 250 MG+250 MG #60"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"## [1] "BRAINMAX"## [1] "BRAINMAX CAPS 250 MG+250 MG #40"## [1] "BRAINMAX CAPS 250 MG+250 MG #60"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs